Biogen
BIIB
$208.90
Share price
3.18%
Change (1 day)
-27.48%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) - Cash on Hand
Cash on Hand as of December 2023 : $1.04 B
According to Biogen's latest financial reports the company has $1.04 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biogen - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.04 B | -78.54% |
| 2022-12-31 | $4.89 B | 28.67% |
| 2021-12-31 | $3.80 B | 45.68% |
| 2020-12-31 | $2.61 B | -41.69% |
| 2019-12-31 | $4.47 B | 26.51% |
| 2018-12-31 | $3.53 B | -4.09% |
| 2017-12-31 | $3.68 B | -24.64% |
| 2016-12-31 | $4.89 B | 42.78% |
| 2015-12-31 | $3.42 B | 85.79% |
| 2014-12-31 | $1.84 B | 50.92% |
| 2013-12-31 | $1.22 B | -28.32% |
| 2012-12-31 | $1.70 B | 0.89% |
| 2011-12-31 | $1.69 B | 39.98% |
| 2010-12-31 | $1.20 B | -4.43% |
| 2009-12-31 | $1.26 B | -5.83% |
| 2008-12-31 | $1.34 B | 13.39% |
| 2007-12-31 | $1.18 B | 31.11% |
| 2006-12-31 | $0.90 B | 6.1% |
| 2005-12-31 | $0.85 B | 306.19% |
| 2004-12-31 | $0.20 B | -33.48% |
| 2003-12-31 | $0.31 B | -60.03% |
| 2002-12-31 | $0.78 B | -1.29% |
| 2001-12-31 | $0.79 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 2,083.73% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 1,108.69% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 1,120.69% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 942.38% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 845.63% | 🇫🇷 France |
 Gilead Sciences GILD | $7.26 B | 591.88% | 🇺🇸 USA |
 Illumina ILMN | $1.05 B | 0.39% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $32.46 M | -96.91% | 🇺🇸 USA |
 Qiagen QGEN | $1.05 B | 0.75% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | $1.60 B | 53.08% | 🇺🇸 USA |